INLB Item 9 Labs Corp.

Item 9 Labs Corp. produces cannabis and cannabis-related products in the United States. It offers products in various categories, such as flower; concentrates; distillates; and hardware. The company provides medical cannabis strains, shatter, crumble, badder, THCA, Delta 8 THC, broad spectrum distillate, and live resin terpene sauce. It offers products through licensed dispensaries to consumers in Arizona. The company is headquartered in Phoenix, Arizona.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$1.00    OTCQX
As of 01/27/2022     OTCMarkets


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  
IPO date:  11/30/2018
Outstanding shares:  94,916,782
Average volume:  9,341
Market cap:   $99,662,621
Current dividend yield:  0.00%
Sedol:      
Valuation   (See tab for details)
PE ratio:   -9.14
PB ratio:   1.16
PS ratio:   4.54
Return on equity:   -12.67%
Net income %:   -49.71%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy